Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41668,231,0.94 [0.74-1.20],0.6362607282171624
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43096,326,0.90 [0.73-1.11],0.3229198574248105
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42651,2257,0.94 [0.87-1.02],0.1412662652692295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Candidiasis,43133,697,1.11 [0.99-1.25],0.0647845404434471
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41809,5745,1.01 [0.96-1.05],0.7583227314259801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42015,5216,0.99 [0.94-1.04],0.6488483115642587
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42716,1991,1.01 [0.93-1.09],0.8391655126143658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,42980,143,1.04 [0.78-1.37],0.8018661274510909
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39770,1549,0.99 [0.91-1.09],0.8919695054517026
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38376,1729,0.96 [0.88-1.05],0.3642734348310922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38269,409,0.97 [0.81-1.16],0.7507542468041442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30273,3210,0.98 [0.92-1.05],0.5453553626014442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38017,633,0.98 [0.85-1.13],0.8239610020653596
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43068,2343,1.01 [0.94-1.08],0.8505510063077704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Mycoses,43256,820,1.08 [0.97-1.21],0.1657219160349038
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41897,1503,0.99 [0.90-1.08],0.7629236037253866
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43147,1710,0.99 [0.91-1.08],0.8388377405867948
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41053,328,0.90 [0.73-1.11],0.3210807491817184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43347,77,1.33 [1.02-1.74],0.0373639731684689
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other septicaemia,42930,1493,1.00 [0.91-1.09],0.9922673285956468
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42963,126,0.89 [0.63-1.26],0.5150444502633692
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other viral diseases,43202,258,1.11 [0.92-1.34],0.266237636769449
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43172,228,1.09 [0.89-1.34],0.4071360712162719
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41078,684,0.84 [0.72-0.98],0.0252519774838513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40843,449,0.98 [0.83-1.16],0.843310442688151
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,40890,165,1.06 [0.82-1.37],0.6711554417622333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43305,90,1.10 [0.79-1.53],0.5654211970147196
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43232,259,0.85 [0.66-1.09],0.1914785463391659
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral warts,43057,84,1.12 [0.80-1.55],0.5145163141239365
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43086,113,0.56 [0.35-0.90],0.0165034346586175
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm,42856,493,0.90 [0.76-1.07],0.2287475155561323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43200,100,0.78 [0.51-1.18],0.2393776887397666
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43158,107,1.17 [0.89-1.53],0.2498828281300706
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19867,104,0.93 [0.64-1.35],0.7055207477457035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42789,2393,0.92 [0.86-1.00],0.0437702759029156
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of meninges,43321,98,1.13 [0.85-1.52],0.4009233574862813
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43233,115,0.74 [0.49-1.12],0.1553086587947388
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43304,175,1.16 [0.93-1.44],0.1969488038500548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of ovary,23372,146,0.84 [0.61-1.16],0.2946275142872766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Ascending colon,43304,610,0.92 [0.79-1.07],0.3002683003023411
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Caecum,43313,493,0.79 [0.65-0.95],0.013740951333882
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43159,116,1.01 [0.73-1.39],0.9595893771376294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Descending colon,43307,367,0.91 [0.75-1.11],0.3700131718399179
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Rectum,43231,582,0.87 [0.74-1.03],0.0999176179481632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43149,1049,1.03 [0.93-1.14],0.5953175538967345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Transverse colon,43297,703,0.93 [0.81-1.07],0.3108861698904596
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Carcinoma in situ of breast,18997,118,0.98 [0.72-1.34],0.9038775982745434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19065,134,0.77 [0.54-1.11],0.1586914189896481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34584,91,0.92 [0.62-1.37],0.6897525162602702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34610,117,1.03 [0.75-1.40],0.8698374073902745
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43258,199,1.11 [0.90-1.38],0.3233617447979782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma, any site",43259,194,1.12 [0.91-1.39],0.2928800460940868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Leiomyoma of uterus,22591,487,1.03 [0.90-1.19],0.6422013305583263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lung cancer and mesothelioma,30097,571,1.01 [0.87-1.18],0.8611395920308669
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lymphoid leukaemia,34582,89,0.90 [0.60-1.35],0.6173654708120655
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34807,314,1.12 [0.95-1.33],0.1755047928278076
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34824,331,1.04 [0.87-1.26],0.64177027368999
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19195,164,1.10 [0.87-1.38],0.4425212176935702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34626,133,0.95 [0.69-1.31],0.752777174681103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34660,167,1.02 [0.78-1.33],0.9129978390480904
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34663,170,1.09 [0.85-1.39],0.5119372741858299
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19159,128,1.04 [0.78-1.38],0.7875613208108502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34647,154,0.88 [0.64-1.21],0.4293806321202794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16606,1144,0.84 [0.75-0.95],0.0058477904445303
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34689,196,1.06 [0.84-1.34],0.623174107070353
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34620,127,0.94 [0.67-1.32],0.7296231409999028
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34664,171,1.24 [1.01-1.51],0.0382992593621434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi,43020,345,0.91 [0.74-1.11],0.3354675636467578
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi of trunk,43280,153,0.99 [0.75-1.30],0.9175765516704332
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanoma in situ,34549,138,1.18 [0.94-1.50],0.1593539670405178
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34648,155,1.04 [0.80-1.36],0.7441498545434788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34760,267,1.00 [0.81-1.24],0.9719776669741188
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34882,389,1.04 [0.87-1.24],0.6938822410991794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34658,165,1.07 [0.84-1.37],0.5743095321345951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Other benign neoplasms of skin,43046,268,1.24 [1.06-1.46],0.0068890081677295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36266,1773,0.99 [0.91-1.07],0.7723268806991237
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36358,1865,1.00 [0.92-1.08],0.9096977981928992
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42836,571,1.09 [0.96-1.24],0.1743180061653656
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40240,146,0.69 [0.47-1.01],0.0544080637156419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42389,124,1.04 [0.78-1.40],0.7750406103596552
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42034,4750,1.00 [0.95-1.06],0.8862139173852741
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,40964,79,0.87 [0.56-1.37],0.5544497582919902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42661,82,0.73 [0.44-1.19],0.2036577394768149
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42560,2466,0.98 [0.91-1.05],0.6181705255738204
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42558,2464,0.98 [0.92-1.05],0.6271138918820619
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40238,144,0.91 [0.66-1.25],0.5495409479102025
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42808,1923,1.03 [0.96-1.11],0.435239995277989
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42773,194,0.87 [0.65-1.15],0.3148721792280419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42370,105,1.16 [0.88-1.54],0.2850437888205532
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42375,110,0.87 [0.60-1.27],0.4672937187649294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43023,444,1.00 [0.85-1.18],0.961970324372318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43173,90,1.21 [0.92-1.61],0.1779362480091413
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",42951,372,1.07 [0.91-1.27],0.3935734844429066
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41051,166,1.00 [0.77-1.31],0.979670369233872
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33647,504,0.99 [0.84-1.16],0.8696050552112098
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40407,192,0.90 [0.68-1.18],0.4348393063607867
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40426,211,0.98 [0.76-1.27],0.885546493328437
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33236,93,0.90 [0.61-1.34],0.6131624918072986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40264,103,0.74 [0.48-1.15],0.1762211274192801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39361,379,1.02 [0.86-1.22],0.7964038493956291
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42588,895,0.83 [0.73-0.96],0.009799093320061
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42145,452,0.90 [0.75-1.08],0.2608841478203418
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,41870,177,0.91 [0.68-1.21],0.5086556440806558
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42774,2613,0.99 [0.93-1.06],0.826861387548805
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37851,2543,1.00 [0.93-1.06],0.887671060154569
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33249,106,0.82 [0.55-1.23],0.3319355808224705
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40060,137,1.18 [0.93-1.49],0.1750860494534234
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33593,450,0.97 [0.82-1.15],0.7212705201872706
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33246,103,0.71 [0.45-1.10],0.12679224423887
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39028,5885,0.99 [0.94-1.03],0.5252670152041593
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33470,327,0.95 [0.78-1.17],0.6473247840462482
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34056,913,0.96 [0.86-1.09],0.5472394406615639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43219,524,1.03 [0.89-1.19],0.7255461650932318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,42903,208,1.10 [0.89-1.36],0.3750345329442914
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33352,209,1.15 [0.94-1.39],0.1767269886378619
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33243,100,1.13 [0.84-1.52],0.4094341754104165
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42447,2524,1.04 [0.97-1.11],0.2644883676243438
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33554,411,1.13 [0.98-1.31],0.0984265414170377
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33590,447,1.12 [0.97-1.29],0.1245723196338726
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34196,1053,1.04 [0.94-1.16],0.3989118891219803
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33320,177,0.95 [0.72-1.25],0.7126166269228003
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,42891,196,1.10 [0.88-1.37],0.3981858769452984
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34131,988,1.01 [0.91-1.13],0.7928134811268399
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,33948,805,1.01 [0.89-1.13],0.912360577645858
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39090,108,1.32 [1.05-1.65],0.0173224263091475
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41441,8298,0.98 [0.95-1.02],0.3684053071782948
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,39996,73,0.91 [0.59-1.40],0.6576964095585116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40020,97,0.83 [0.56-1.25],0.3740615923810998
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43046,3222,0.98 [0.92-1.04],0.5086307013637484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43048,3218,0.98 [0.92-1.04],0.528327418161445
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40007,84,0.52 [0.30-0.92],0.0244082835688887
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42772,2024,1.07 [1.00-1.15],0.0523064072645137
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35720,2577,1.02 [0.95-1.09],0.5855228535735146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43328,346,1.01 [0.83-1.22],0.9469205552866188
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41816,123,0.81 [0.55-1.19],0.2821317939214104
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,40927,179,0.94 [0.71-1.23],0.6397833278570354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,40987,239,0.97 [0.77-1.21],0.7661684061887085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33415,272,1.09 [0.91-1.31],0.3559048272494419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39468,258,1.15 [0.96-1.38],0.1342725340879013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3549,140,1.05 [0.77-1.43],0.7720408669797336
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3781,416,1.03 [0.86-1.23],0.7518811854809708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39312,102,1.16 [0.87-1.55],0.3228212849808428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3486,78,1.22 [0.84-1.77],0.2920459654154866
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42308,3098,0.96 [0.90-1.02],0.2154674519350984
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42253,560,0.92 [0.78-1.08],0.3082403828495918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39590,608,0.85 [0.72-1.00],0.0461510718265341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34362,1219,0.99 [0.90-1.10],0.905178809667317
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43160,411,0.96 [0.80-1.14],0.6154306569042045
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41460,271,0.97 [0.77-1.21],0.7620606778032599
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Angina pectoris,39652,1967,1.04 [0.97-1.12],0.299454896433162
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Aortic aneurysm,41588,399,0.99 [0.83-1.19],0.9105539275633638
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41285,96,1.13 [0.83-1.56],0.4350209302490005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41517,328,1.04 [0.86-1.25],0.7001670543392959
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26888,3125,0.99 [0.93-1.05],0.7244897678282503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,AV-block,36646,701,0.95 [0.83-1.09],0.4715415526243501
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43247,681,0.94 [0.82-1.08],0.3993927180428454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiac arrest,24079,316,0.90 [0.72-1.12],0.3411310283741093
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiomyopathy,36232,287,0.91 [0.73-1.14],0.4315530804114132
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36105,160,0.88 [0.64-1.19],0.402385268626685
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43345,77,1.14 [0.80-1.61],0.4766537348263946
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Conduction disorders,37654,1709,0.98 [0.90-1.07],0.703773421995509
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41112,3459,0.97 [0.92-1.03],0.3680820074058838
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,37946,12735,1.00 [0.97-1.03],0.7989000472052383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,DVT of lower extremities,41053,443,0.95 [0.80-1.12],0.5247342076493574
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Endocarditis,36061,116,0.76 [0.51-1.14],0.1783214520719582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Heart failure, strict",42995,1791,1.00 [0.92-1.09],0.9471348146480908
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertension,39462,10897,1.01 [0.97-1.04],0.7008203520550624
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, essential",39474,10909,1.01 [0.97-1.04],0.6976626088701279
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, portal",43054,128,1.21 [0.94-1.54],0.1385892391847446
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28876,311,1.04 [0.85-1.26],0.7104193495518094
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28727,162,0.88 [0.64-1.20],0.4212044898114614
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypotension,43114,1880,0.91 [0.83-0.99],0.0270415598570512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41825,179,1.11 [0.88-1.40],0.3833849983205513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41396,3711,0.97 [0.91-1.03],0.3077403430792552
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42740,936,1.01 [0.90-1.13],0.8719309269363451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Left bundle-branch block,36536,591,1.00 [0.86-1.15],0.9619379741373238
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42571,1394,0.95 [0.86-1.05],0.3510437888606668
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38857,1172,0.93 [0.83-1.04],0.1978813730038033
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43186,264,0.94 [0.75-1.19],0.6208905068026498
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43296,512,1.06 [0.92-1.23],0.4094029159966952
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Oesophageal varices,40699,89,0.99 [0.68-1.45],0.9773989861841648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other aneurysm,41317,128,0.84 [0.59-1.20],0.339740578120548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arrhythmias,36654,709,0.90 [0.78-1.04],0.1696233524717803
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41357,168,1.03 [0.79-1.34],0.8373161831559897
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41584,395,1.08 [0.91-1.26],0.3794290498967154
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36242,297,0.96 [0.78-1.19],0.7166665993109242
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other disorders of veins,40757,147,0.88 [0.64-1.22],0.4459493358608143
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40693,83,1.11 [0.79-1.55],0.5403756278395713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,40975,104,0.89 [0.61-1.31],0.5601705678525498
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40829,219,0.98 [0.77-1.24],0.8461690543216283
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37631,1686,0.98 [0.90-1.07],0.7116398763745181
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41323,89,1.22 [0.92-1.62],0.1706727173157742
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42088,899,0.97 [0.86-1.09],0.6403695950902177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42318,584,1.06 [0.93-1.22],0.3841496161697264
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",41871,1000,0.98 [0.87-1.09],0.6686437603705699
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24319,556,0.99 [0.86-1.15],0.9303286452744182
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Peripheral artery disease,41801,663,0.92 [0.79-1.07],0.2773395630608005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41180,570,0.95 [0.81-1.10],0.4957667818018406
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Pulmonary embolism,42513,779,0.96 [0.85-1.09],0.5450102810715663
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43224,1065,0.94 [0.84-1.06],0.3008719890661503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Right bundle-branch block,36509,564,0.94 [0.81-1.10],0.470220681666754
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Secondary right heart disease,42311,577,1.07 [0.93-1.23],0.3401490641808047
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41188,317,1.00 [0.83-1.22],0.9668477088509864
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42718,1072,1.01 [0.91-1.12],0.8403624077126921
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42685,1135,1.01 [0.91-1.12],0.8633341575041584
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41780,97,0.94 [0.66-1.36],0.7584753069739367
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41318,130,1.00 [0.74-1.36],0.9803747265469288
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Transient ischemic attack,42174,370,0.99 [0.83-1.19],0.9196478174659936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41607,430,0.95 [0.80-1.14],0.5888080922282771
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Varicose veins,41292,682,0.87 [0.75-1.02],0.078596473552812
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41215,144,1.06 [0.81-1.39],0.6639639009859502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Venous thromboembolism,42961,1229,0.95 [0.85-1.05],0.3124228586316628
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43134,602,1.00 [0.87-1.15],0.9743569154357944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",37966,2385,1.04 [0.98-1.11],0.2264334863646694
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Any mental disorder,42253,6672,1.00 [0.95-1.04],0.8452101921056685
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43054,704,0.99 [0.87-1.13],0.8909572925138672
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38242,2661,0.99 [0.92-1.05],0.6648126032419802
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35716,135,0.82 [0.57-1.17],0.2654942169930503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Smoking dependency,42441,2305,1.01 [0.94-1.09],0.8359642636579925
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38312,2731,0.99 [0.93-1.06],0.8677796884452726
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Vascular dementia,42543,211,0.94 [0.73-1.22],0.6560916250768509
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Alzheimer disease,43345,561,0.87 [0.73-1.02],0.0940554472915658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29383,101,0.79 [0.52-1.22],0.2874851457180456
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Bell's palsy,40365,138,0.90 [0.65-1.24],0.5185672699348103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41067,840,1.07 [0.96-1.19],0.2542510766045397
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral cysts,42675,383,1.07 [0.91-1.26],0.4224873392908512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43210,518,0.98 [0.84-1.15],0.8192627394973975
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42532,93,0.99 [0.69-1.42],0.958630855278804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43320,102,0.93 [0.65-1.35],0.7191883578620837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42413,121,1.16 [0.89-1.51],0.2761525600681994
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Epilepsy,40781,467,0.96 [0.82-1.14],0.6592804643935499
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42542,2228,0.98 [0.91-1.05],0.5769464257592851
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43271,695,1.01 [0.89-1.15],0.8927697924212038
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Falls/tendency to fall,42351,4229,1.00 [0.95-1.06],0.8905164628036368
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Generalized epilepsy,42723,93,1.13 [0.83-1.54],0.4334122691162626
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hemiplegia,43099,407,1.02 [0.86-1.20],0.851142595325851
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hydrocephalus,42393,101,0.71 [0.45-1.11],0.1316428947347283
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43311,116,0.73 [0.48-1.10],0.1274543802612868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40357,130,1.21 [0.96-1.53],0.1029679700255594
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40362,135,0.74 [0.51-1.09],0.1269251500240981
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Memory loss,42298,192,1.06 [0.84-1.33],0.6480317156838038
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Migraine,40904,590,1.03 [0.90-1.17],0.7144548350749872
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43229,538,1.03 [0.90-1.18],0.6728109859839171
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Motor neuron disease,29570,252,1.01 [0.82-1.26],0.9078079897960492
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43047,176,1.17 [0.95-1.44],0.1313332638902969
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42229,2002,1.03 [0.96-1.11],0.3826296633096082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Neurological diseases,40846,6075,1.01 [0.97-1.06],0.5698458062178184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42739,300,1.00 [0.81-1.22],0.9738611516969664
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40892,665,0.97 [0.84-1.11],0.6565556336883089
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43218,481,0.94 [0.80-1.12],0.5010449177998473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34680,1067,0.99 [0.89-1.11],0.9038550438398348
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42410,118,1.01 [0.74-1.38],0.9468492535164172
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other disorders of nervous system,42525,233,0.86 [0.67-1.12],0.2710160646830722
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42827,251,0.96 [0.76-1.20],0.7006979127863586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other facial nerve disorders,40389,162,0.89 [0.66-1.21],0.4632919361965538
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other headache syndromes,40414,100,0.85 [0.57-1.26],0.4220895322399927
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other neurological diseases,43148,856,0.98 [0.87-1.11],0.7420733309148111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other sleep disorders,41225,911,0.96 [0.85-1.08],0.4676734175462383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Parkinson's disease,43303,408,1.09 [0.94-1.27],0.2671756054209979
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42384,92,0.98 [0.68-1.39],0.8920470201740125
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Restless leg syndrome,43343,112,0.97 [0.69-1.35],0.8363736480433754
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Sleep apnoea,42948,789,0.96 [0.84-1.09],0.5006419791122153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Small fibre neuropathy,42817,80,0.89 [0.58-1.37],0.5967713513187745
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43318,298,1.02 [0.84-1.24],0.8512868356544625
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40316,89,0.87 [0.58-1.32],0.5121525829274376
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43345,567,0.87 [0.74-1.03],0.1062121980909208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42476,204,0.95 [0.74-1.24],0.7199019032160772
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42394,162,1.10 [0.86-1.40],0.437634047033554
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42668,663,1.05 [0.92-1.19],0.4726875894946623
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43071,390,0.99 [0.83-1.19],0.9444042222453164
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41673,91,0.88 [0.59-1.32],0.5388263313545008
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41681,99,1.05 [0.76-1.45],0.7589639273500021
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43163,92,0.90 [0.60-1.34],0.5918426794687943
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,42918,249,0.93 [0.74-1.18],0.5525886164667719
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3493,84,1.17 [0.81-1.68],0.4050945107680992
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4235,161,1.03 [0.78-1.37],0.8126072806796981
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42396,164,0.97 [0.74-1.28],0.8495687328543239
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43006,1729,1.02 [0.94-1.11],0.6374850861252833
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42724,1142,1.03 [0.93-1.14],0.5694441747356419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41956,374,1.00 [0.84-1.19],0.994851188220063
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43213,1208,1.03 [0.94-1.13],0.5651466647249592
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43331,117,0.91 [0.65-1.29],0.6117393611162356
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43093,1088,1.06 [0.96-1.17],0.2268055255417259
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43274,605,0.98 [0.85-1.13],0.8290102973720361
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43186,300,0.95 [0.77-1.17],0.6315851415949644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41680,98,1.18 [0.88-1.58],0.2637334529182489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41693,111,0.96 [0.67-1.36],0.8017315765375661
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41678,96,0.97 [0.68-1.39],0.8696757185229863
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43193,1182,0.98 [0.88-1.08],0.6778187598419272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42319,308,1.02 [0.84-1.23],0.8605658352843681
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42082,77,0.94 [0.62-1.42],0.7608833969569798
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42834,165,1.03 [0.79-1.33],0.8465878194228256
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43122,453,0.95 [0.80-1.13],0.5548206142014884
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42331,326,1.12 [0.95-1.32],0.1816887565752417
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43063,177,0.94 [0.71-1.23],0.6484735498075543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42784,773,0.94 [0.83-1.08],0.3899037217281017
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42465,233,1.07 [0.87-1.32],0.535329944362247
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40707,3649,1.00 [0.94-1.06],0.8975488103160942
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43067,398,0.97 [0.82-1.16],0.7638840056380718
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43308,259,1.11 [0.91-1.34],0.2983560373301175
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42257,675,1.01 [0.88-1.15],0.935167527075558
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42780,111,1.03 [0.75-1.42],0.8692664743256284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43308,94,1.03 [0.73-1.45],0.8623696776441071
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41726,144,1.28 [1.05-1.57],0.0166967758763392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41832,250,1.08 [0.89-1.32],0.4461572468708055
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41470,193,0.98 [0.76-1.27],0.8703710281680467
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42101,96,0.89 [0.60-1.31],0.5427715801370485
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41388,111,0.86 [0.59-1.25],0.4288431223046272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42155,144,0.94 [0.69-1.27],0.6654155897382064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42332,321,0.78 [0.61-0.99],0.0404677598078251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41784,202,0.84 [0.63-1.12],0.2362428934610715
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41458,181,1.18 [0.96-1.45],0.1123583508214357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41410,133,1.07 [0.81-1.41],0.6462489575992518
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40025,2967,1.01 [0.95-1.08],0.6547734624231413
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41707,125,0.98 [0.72-1.34],0.911039616395372
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42919,687,1.04 [0.91-1.18],0.5645019953386632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42326,94,1.10 [0.80-1.52],0.5648643553236368
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42497,265,0.97 [0.78-1.21],0.8076018904915678
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,42972,146,0.84 [0.60-1.17],0.3064378985093548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43272,197,1.14 [0.92-1.40],0.2359947180629632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43130,220,0.87 [0.66-1.13],0.2841325472251357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,42931,105,0.97 [0.69-1.37],0.8509374123417034
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,42933,107,1.20 [0.93-1.56],0.1626613512936618
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43167,1461,1.07 [0.98-1.16],0.1229237280752349
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42752,1046,1.03 [0.92-1.14],0.6262891739500782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,41913,207,1.20 [0.99-1.46],0.0704746823167035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41848,142,1.36 [1.12-1.65],0.0015686940004022
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute pharyngitis,42926,120,1.01 [0.74-1.37],0.956604656792168
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43165,359,0.97 [0.81-1.17],0.765022746635609
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,42912,106,1.04 [0.75-1.43],0.8199655602202804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza,40056,188,1.06 [0.84-1.35],0.6244106512257275
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40053,185,1.07 [0.85-1.36],0.5516873031578662
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic asthma (mode),29727,201,1.07 [0.85-1.34],0.5781100792267244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic rhinitis,43140,477,0.95 [0.81-1.12],0.5569020573507774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32081,2998,1.03 [0.97-1.09],0.3895419593619759
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32480,2954,1.02 [0.96-1.09],0.4669021856773629
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42670,230,1.01 [0.81-1.27],0.9203892197381264
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40002,134,0.85 [0.60-1.21],0.3749365543347192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bronchiectasis,37521,580,1.11 [0.98-1.26],0.0912102052159614
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37035,94,0.73 [0.47-1.16],0.1829308694459448
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41638,4697,1.02 [0.97-1.07],0.462383137181559
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41016,126,1.00 [0.73-1.35],0.9813741099249408
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic sinusitis,41145,255,1.01 [0.82-1.25],0.9083692273901622
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43016,1970,0.96 [0.89-1.05],0.3818502099860517
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Deviated nasal septum,41076,186,0.82 [0.61-1.11],0.2029253116109618
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39854,8759,1.01 [0.97-1.04],0.7364839468699013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41519,629,0.94 [0.81-1.08],0.3774523473117311
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Early onset COPD,41596,550,0.93 [0.80-1.09],0.3712581927491911
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Emphysema,37463,522,1.04 [0.90-1.21],0.5819796437569491
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41106,488,1.22 [1.07-1.38],0.0019775279118641
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Influenza and pneumonia,42967,3099,1.04 [0.98-1.11],0.1988180372798609
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Interstitial lung disease,41163,545,1.18 [1.04-1.34],0.0082042002285214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Later onset COPD,41623,1420,0.98 [0.89-1.08],0.6586034264032663
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43324,515,0.96 [0.82-1.13],0.6421176033766361
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Nasal polyp,41074,184,0.83 [0.61-1.12],0.2291038136499734
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42913,1598,0.94 [0.86-1.03],0.2178116491159231
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of pleura,42945,3311,1.00 [0.95-1.07],0.8780364791370503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42313,1423,0.96 [0.88-1.06],0.4224307389869159
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other pleural conditions,39718,84,1.02 [0.70-1.48],0.9080030112480926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43182,674,1.16 [1.04-1.30],0.00918969012694
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43160,2174,0.98 [0.90-1.05],0.5375137355846991
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural effusion,41259,1625,1.01 [0.93-1.10],0.8196405589295805
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural plaque,39895,261,1.10 [0.89-1.35],0.3731859800193878
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42549,2681,1.03 [0.96-1.10],0.3992822650491515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43212,403,0.92 [0.76-1.11],0.3642354670666111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumothorax,39837,203,1.08 [0.86-1.36],0.4970568141801609
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pollen allergy,43307,406,0.99 [0.84-1.18],0.9416823364761316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pulmonary oedema,42617,109,0.96 [0.68-1.37],0.8273457455907658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Respiratory insufficiency,29617,91,0.75 [0.47-1.21],0.2424694580169026
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42879,1564,0.95 [0.86-1.04],0.2684114164755729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41368,478,0.95 [0.80-1.12],0.5116517331180708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Viral pneumonia,40272,404,1.02 [0.86-1.21],0.8430162827133612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42700,332,0.99 [0.82-1.20],0.9269873692625684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20024,187,0.87 [0.64-1.17],0.3415763630839668
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30709,106,0.95 [0.66-1.36],0.7726467780873918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute appendicitis,43070,239,1.00 [0.80-1.24],0.980930873965233
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute gastritis,32686,140,1.28 [1.03-1.58],0.0243513518825778
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis,40271,309,0.84 [0.67-1.06],0.149297882863591
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute peritonitis,42554,150,0.95 [0.70-1.28],0.7157373351190646
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Alcoholic liver disease,41859,122,1.21 [0.94-1.56],0.1332452505757508
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Barrett oesophagus,33269,723,1.03 [0.91-1.16],0.6710026406634684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40128,166,0.92 [0.69-1.24],0.5887672499017199
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42647,166,0.92 [0.69-1.24],0.5962353791973227
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholecystitis,40292,330,0.99 [0.82-1.20],0.9250929792946272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholelithiasis,41649,1687,0.98 [0.90-1.07],0.6406882361838124
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic gastritis,33046,500,1.00 [0.86-1.17],0.9951046418008712
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic pancreatitis,40042,80,0.80 [0.50-1.28],0.3506852602381903
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43106,180,1.10 [0.87-1.39],0.4387594029432514
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Coeliac disease,40658,199,1.39 [1.20-1.61],1.2790753919322225e-05
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Collagenous colitis,40515,135,0.84 [0.59-1.18],0.3125646096803482
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43078,323,1.08 [0.90-1.28],0.4095835736016611
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Constipation,42916,2736,1.00 [0.94-1.07],0.9716030359083762
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn disease,40526,146,0.90 [0.66-1.23],0.5138987986102843
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42746,102,1.06 [0.77-1.46],0.736606024504009
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn's disease NAS,40516,136,0.80 [0.56-1.14],0.2078945482160272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Dental caries,42100,388,1.14 [0.99-1.33],0.0763515664418704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,38941,3703,1.03 [0.98-1.09],0.2868951875214148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of appendix,43133,302,1.01 [0.83-1.22],0.9588312195089056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of liver,43144,1407,0.97 [0.88-1.06],0.4724819954805983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39709,7163,1.03 [0.99-1.07],0.1189988666307761
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42633,921,1.07 [0.96-1.19],0.2138212257836229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of peritoneum,43198,794,0.95 [0.83-1.08],0.4088863944913066
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41903,191,0.98 [0.76-1.27],0.8962586382717764
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of salivary glands,41661,104,0.98 [0.70-1.38],0.9048345811089474
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of the digestive system,42821,2362,1.03 [0.97-1.11],0.3222271601926101
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of tongue,41679,187,1.22 [1.00-1.48],0.0505241070984575
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42321,2359,0.96 [0.90-1.04],0.3250271161549449
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,35897,5294,1.01 [0.97-1.06],0.5898371334881765
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Duodenal ulcer,32874,328,0.91 [0.74-1.12],0.382170451219775
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43196,261,0.84 [0.65-1.08],0.1712152070851745
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43201,89,1.06 [0.76-1.47],0.7394178340353186
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,41954,217,1.03 [0.81-1.29],0.8256579176258563
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30852,249,1.00 [0.81-1.25],0.9811483904075244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Functional dyspepsia,33467,921,1.00 [0.89-1.12],0.9879125837877312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastric ulcer,33152,606,0.96 [0.83-1.12],0.6269258392574594
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36720,4174,1.02 [0.97-1.07],0.5054238224096579
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33444,898,0.96 [0.85-1.08],0.5178097727572295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33574,13828,1.03 [1.00-1.06],0.0634952588817777
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,GI-bleeding,42380,1921,0.99 [0.92-1.07],0.8311356873765333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41818,106,1.14 [0.86-1.50],0.3538286035151538
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32221,2095,0.96 [0.89-1.04],0.3245105655070024
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41842,105,1.17 [0.88-1.55],0.2832513797216922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Hernia,40621,5383,1.00 [0.95-1.05],0.9362949332577726
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impacted teeth,43212,83,1.12 [0.81-1.54],0.5063882763915011
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impaction of intestines,30698,95,0.84 [0.56-1.27],0.4106142911611876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Inguinal hernia,36738,1500,0.97 [0.88-1.06],0.4947304939545542
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35407,169,1.14 [0.90-1.45],0.2732306242755795
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30762,159,0.94 [0.70-1.26],0.6645274443102861
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal malabsorption,40697,238,1.33 [1.15-1.54],0.0001223517858792
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31538,935,0.98 [0.88-1.10],0.7399269220151428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43301,603,0.88 [0.75-1.03],0.103529246571507
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41643,1263,1.08 [0.98-1.17],0.1053050623025324
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42059,1679,1.07 [0.99-1.15],0.0948842993355833
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophageal obstruction,32855,309,0.94 [0.76-1.15],0.5331505854959089
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophagitis,33558,1012,1.04 [0.94-1.15],0.4742632964090276
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43255,229,0.97 [0.77-1.22],0.8143167729278407
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35351,113,1.05 [0.77-1.43],0.7624458392134661
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32874,2271,1.01 [0.94-1.08],0.8066601603939767
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40424,462,0.96 [0.81-1.13],0.6108107137911791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40223,261,1.09 [0.90-1.32],0.3596234394542287
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestine,33539,2936,1.00 [0.94-1.06],0.9451541364782698
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestines,39987,9384,1.00 [0.97-1.04],0.978350620853802
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41644,349,1.02 [0.86-1.22],0.7964492085213906
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of liver,42877,1140,0.95 [0.85-1.06],0.3237100778107298
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33648,1102,1.01 [0.91-1.12],0.9099369807556192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of pancreas,40207,245,0.96 [0.76-1.21],0.7119774446870916
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43089,685,0.94 [0.82-1.08],0.4066882513450187
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34125,1579,1.02 [0.94-1.11],0.6797810970303946
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42406,1947,0.99 [0.91-1.07],0.7659660910671051
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42002,290,1.05 [0.87-1.27],0.6213213741343275
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33421,2818,1.01 [0.95-1.08],0.7991583211554177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35883,3337,1.03 [0.97-1.09],0.3000220150226926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,41900,163,1.12 [0.89-1.42],0.3420192368983223
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41858,1478,1.06 [0.97-1.15],0.197374163967172
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31169,566,0.92 [0.79-1.08],0.3170956596100177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43183,103,1.09 [0.81-1.47],0.5632125097939539
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31412,809,0.97 [0.86-1.10],0.6621651968580133
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40715,256,1.05 [0.85-1.28],0.6730593301450851
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Recurring oral aphthae,43323,100,0.84 [0.57-1.25],0.3979558285842662
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41718,201,0.98 [0.77-1.25],0.8741675085642582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Toxic colitis,40472,92,1.07 [0.77-1.50],0.6801414880023795
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33000,454,0.93 [0.78-1.11],0.4232901715904003
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcerative colitis,40648,268,1.13 [0.94-1.35],0.1815960497523085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40604,224,0.96 [0.75-1.22],0.7292231348663526
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Umbilical hernia,35690,452,0.86 [0.71-1.04],0.1204961231998906
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,30898,295,1.02 [0.84-1.25],0.8147578462771642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ventral hernia,35662,424,1.06 [0.90-1.24],0.5053782981762598
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Volvulus,30736,133,1.03 [0.77-1.38],0.8376700546817238
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43218,474,1.15 [1.00-1.31],0.0463069776382346
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42812,133,0.97 [0.72-1.32],0.8509575710977862
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39970,270,0.94 [0.76-1.17],0.5987428224387692
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42247,1162,0.90 [0.81-1.01],0.0677088643585318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41386,301,1.14 [0.96-1.35],0.1297940121567108
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40340,640,1.04 [0.91-1.19],0.5207705853419875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42831,462,1.01 [0.86-1.18],0.8912592326567452
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43166,797,1.04 [0.93-1.17],0.5158700740526316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42448,79,1.11 [0.79-1.56],0.5511024907915592
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40703,5301,1.00 [0.95-1.05],0.9063277778339688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42567,737,1.02 [0.90-1.15],0.7269949127234325
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42346,516,1.06 [0.92-1.22],0.4348573939197316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42668,1583,0.97 [0.88-1.06],0.4632452995999442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43317,89,0.86 [0.57-1.30],0.4808938292409273
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39809,109,0.67 [0.43-1.04],0.0748802969398129
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41916,86,0.77 [0.48-1.23],0.2676566266960527
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42813,444,1.02 [0.87-1.20],0.7616680825079596
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40449,749,0.98 [0.86-1.12],0.7770952117637626
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39808,108,1.02 [0.73-1.42],0.910139234670937
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43197,132,1.14 [0.89-1.47],0.3004007629130043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41386,301,1.01 [0.83-1.23],0.9502863959236668
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43003,324,1.02 [0.84-1.23],0.8369195487407005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42465,96,0.93 [0.64-1.37],0.7205512355302786
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39803,103,1.28 [1.00-1.64],0.046269011292357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42372,2672,0.98 [0.92-1.05],0.5546326429251064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40517,817,0.94 [0.83-1.07],0.3838264340303222
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39815,115,0.99 [0.72-1.38],0.975850233742704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43197,518,0.99 [0.85-1.16],0.9288386889318064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42488,119,1.09 [0.82-1.45],0.5388859197099756
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43105,426,1.02 [0.86-1.20],0.8378216092844263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43260,516,1.14 [1.00-1.30],0.0444788219412406
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39916,216,1.00 [0.79-1.25],0.9721329745842052
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40143,443,1.06 [0.91-1.23],0.4496273224152417
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43243,499,1.14 [1.00-1.30],0.0448197039571342
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40078,378,0.87 [0.71-1.07],0.1796962531522901
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43290,225,1.15 [0.95-1.40],0.1393242609785027
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37184,179,1.10 [0.88-1.38],0.4087647463937929
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39437,9431,0.97 [0.93-1.00],0.0794423874851695
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37077,7071,0.98 [0.94-1.02],0.4201000390504505
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37132,127,1.23 [0.98-1.56],0.0733493371372005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37642,251,0.91 [0.72-1.16],0.4466421050522805
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37684,293,1.01 [0.82-1.23],0.953960633623914
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,42924,152,0.90 [0.67-1.22],0.5037201711249603
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37554,163,0.93 [0.70-1.25],0.6386665265179463
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31918,1912,0.96 [0.88-1.04],0.2757228633825074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43109,322,0.84 [0.68-1.05],0.1359032361959497
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38111,720,0.96 [0.84-1.10],0.5515640666500092
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36637,12147,0.98 [0.95-1.01],0.2212178697350948
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40037,194,0.85 [0.64-1.13],0.2679250029276443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37255,250,1.01 [0.81-1.26],0.9256555666648416
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37968,963,0.97 [0.86-1.08],0.5382690850865143
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41783,4392,1.00 [0.95-1.05],0.985254829549064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37469,464,1.02 [0.88-1.20],0.7619289267272079
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37389,384,1.08 [0.93-1.26],0.3203229556408672
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37242,237,1.03 [0.83-1.27],0.804413292432316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42229,120,0.91 [0.64-1.28],0.5746141295378964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32823,2817,0.97 [0.90-1.03],0.3204801239519791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30972,966,0.88 [0.78-1.00],0.0538341230702395
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43213,950,0.90 [0.79-1.02],0.10759693211117
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30136,130,0.90 [0.65-1.25],0.5228317330931707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30569,563,0.94 [0.81-1.09],0.3977228377520252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37510,505,1.05 [0.91-1.21],0.5313502365991164
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31082,1076,1.02 [0.92-1.13],0.7260868741310391
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37481,90,0.91 [0.61-1.35],0.6305673996813277
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38433,1042,0.91 [0.81-1.02],0.1039662669626479
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37892,501,0.97 [0.82-1.13],0.6668248979770227
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31005,999,1.02 [0.92-1.13],0.74126956806605
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37134,129,0.89 [0.63-1.25],0.5018914155720338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37105,100,1.23 [0.95-1.60],0.1193284908935702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,39959,116,0.84 [0.57-1.23],0.374834676128056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42700,2857,1.04 [0.98-1.11],0.1753922780203198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41720,1877,1.10 [1.03-1.18],0.0077773083065338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43102,759,1.06 [0.94-1.19],0.3644347429230061
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34168,4162,1.00 [0.94-1.05],0.8761241257053973
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30113,107,0.67 [0.43-1.04],0.0769607227566532
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37159,154,1.27 [1.04-1.55],0.0173079867220648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30097,91,0.95 [0.65-1.39],0.7884195083040819
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30220,214,1.00 [0.80-1.26],0.9949529536722784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40255,412,1.00 [0.84-1.18],0.9629661507682276
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40462,619,0.94 [0.82-1.09],0.4301231381441631
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43295,163,0.91 [0.68-1.22],0.5237545915575026
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40377,2986,0.99 [0.93-1.06],0.7898941964056492
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37172,167,0.99 [0.76-1.29],0.961540933485854
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30239,233,0.82 [0.63-1.07],0.1442157265177936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38598,1207,1.01 [0.92-1.12],0.8164256873215102
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33629,3623,0.96 [0.91-1.02],0.18888737780108
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42266,157,0.98 [0.74-1.30],0.8944563474266809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43313,127,0.92 [0.66-1.28],0.6275140711914602
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37140,135,0.92 [0.66-1.27],0.593771233988702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39070,2065,1.00 [0.92-1.08],0.9358536491533056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37152,147,1.08 [0.84-1.40],0.545769505002128
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32717,2711,0.94 [0.88-1.01],0.1050068605949147
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40043,200,1.05 [0.84-1.32],0.6804232647093047
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37089,84,0.84 [0.54-1.30],0.4325530267254803
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37656,265,1.06 [0.87-1.29],0.5723252345329146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37901,896,0.98 [0.87-1.10],0.7333731415689837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42707,598,0.94 [0.81-1.09],0.4214788833860089
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38336,945,0.99 [0.89-1.11],0.8940199743544969
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43123,740,1.04 [0.92-1.18],0.496274204923821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43308,91,1.12 [0.81-1.54],0.4933899114161054
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37326,321,0.91 [0.74-1.12],0.3977298817610135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34311,1255,0.95 [0.86-1.05],0.3013363347817104
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37959,954,0.95 [0.85-1.07],0.4118170746045821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37392,387,1.02 [0.85-1.21],0.8482657918283191
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30100,94,1.08 [0.78-1.50],0.6406337914867448
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34142,4136,0.97 [0.92-1.02],0.2485091094635399
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31089,1083,1.00 [0.90-1.11],0.988708587601878
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42490,381,0.86 [0.70-1.06],0.1512312109057971
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43235,103,0.94 [0.66-1.35],0.7434019150570512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39734,84,0.98 [0.66-1.45],0.915314137052308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30136,130,0.95 [0.69-1.31],0.7540307291960839
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37562,171,0.79 [0.57-1.09],0.1513857678899985
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30776,770,1.06 [0.94-1.19],0.3510000061745582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37524,519,1.05 [0.91-1.21],0.543110475076454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37823,432,0.97 [0.82-1.15],0.7341117399950179
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37696,305,0.96 [0.78-1.18],0.6796745007749967
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33899,100,0.82 [0.55-1.24],0.347223328110986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43315,98,1.13 [0.83-1.53],0.4315625288967099
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37986,981,1.03 [0.93-1.15],0.5231325524952617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42272,163,1.05 [0.82-1.35],0.7000525104093751
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41307,4302,1.00 [0.95-1.06],0.8711331644503871
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37229,224,0.90 [0.70-1.16],0.4261535128696906
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38269,878,0.98 [0.87-1.11],0.7645583002509723
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,40942,390,0.96 [0.80-1.15],0.65728467878605
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37720,329,0.99 [0.82-1.20],0.9502114565535286
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39938,2547,0.98 [0.92-1.06],0.6627720497501951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39051,1660,0.98 [0.90-1.07],0.6310687904313719
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37091,86,1.49 [1.22-1.83],9.765155739103878e-05
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42355,246,1.10 [0.90-1.33],0.3466625188038004
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37281,276,0.92 [0.74-1.15],0.4729765475334218
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37139,134,0.91 [0.66-1.25],0.553445523543169
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30099,93,0.87 [0.58-1.31],0.5065442136342178
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Acute renal failure,41784,2491,0.99 [0.92-1.06],0.7610158434490992
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17561,87,1.08 [0.78-1.49],0.6401366319881249
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22849,97,1.09 [0.81-1.47],0.5537290393252612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42823,531,0.90 [0.76-1.06],0.1987051151812383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42435,143,1.01 [0.76-1.35],0.9458409020317946
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41556,2263,1.03 [0.96-1.10],0.4357113248011915
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43008,104,1.01 [0.72-1.42],0.954009681889531
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,42978,491,1.08 [0.93-1.25],0.3057486120443894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cystitis,38267,388,0.99 [0.83-1.18],0.9316491942410732
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Dialysis,39403,110,0.85 [0.58-1.26],0.4201577304469676
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18860,2758,0.97 [0.90-1.04],0.3395765576931339
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23025,273,1.03 [0.85-1.24],0.796042092516879
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Endometriosis,17623,149,1.13 [0.89-1.42],0.308978656880084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17808,334,0.99 [0.82-1.18],0.8962580173476945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18338,864,1.02 [0.91-1.14],0.7473156381265644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36234,8817,1.01 [0.98-1.05],0.4511219161560924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43027,123,1.16 [0.89-1.51],0.2741682199427623
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydrocele,16273,171,0.81 [0.58-1.12],0.1936438795238572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39247,467,0.92 [0.77-1.09],0.3402796227751639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18267,2165,0.99 [0.91-1.06],0.7201893173789939
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22963,347,0.86 [0.70-1.05],0.1407639948025607
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16297,195,0.80 [0.59-1.09],0.1560944142841496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Irregular menses,23046,107,1.09 [0.82-1.44],0.5551054331505263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Menorrhagia,17735,261,0.95 [0.76-1.18],0.6257700551917185
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38007,128,1.19 [0.94-1.52],0.1487379959923304
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19554,2080,1.03 [0.96-1.11],0.3852257732665848
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16200,98,1.01 [0.71-1.43],0.955808997878706
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17590,116,1.02 [0.76-1.37],0.9029553661868364
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43330,108,1.17 [0.89-1.53],0.2707051809470686
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43328,108,0.94 [0.66-1.33],0.7200718026614659
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41597,3718,1.00 [0.94-1.06],0.9614387524182276
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39093,1214,1.04 [0.94-1.14],0.4742295312245784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22847,95,1.07 [0.78-1.46],0.6694355696954345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43237,750,1.12 [1.00-1.25],0.0521725489276854
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16357,255,0.94 [0.75-1.19],0.6192746287951285
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16339,237,0.82 [0.62-1.08],0.1495606357597036
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16290,188,0.89 [0.67-1.19],0.4355612257595527
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43283,114,0.74 [0.49-1.12],0.1511368078389351
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40716,2837,0.98 [0.92-1.05],0.59198858307658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22794,178,0.90 [0.68-1.18],0.4389415408727515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17607,133,1.09 [0.84-1.41],0.5275620717048224
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17803,329,1.11 [0.94-1.30],0.2322073557986035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17574,100,1.05 [0.77-1.43],0.7613951264793682
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17650,176,0.81 [0.59-1.09],0.16641918677272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39327,547,0.94 [0.80-1.10],0.4313700139839731
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42733,246,1.15 [0.96-1.39],0.1378631428226867
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17737,263,1.09 [0.91-1.31],0.3433811167246021
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17562,88,0.84 [0.56-1.27],0.4020443877664712
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18013,539,0.95 [0.81-1.10],0.4857904542281416
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17612,138,0.92 [0.68-1.25],0.6059825115907294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17968,494,1.03 [0.89-1.19],0.7226664217496352
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,42990,86,0.61 [0.36-1.04],0.0717310022640538
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16320,218,0.78 [0.58-1.05],0.1008712551765012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,42984,4204,1.00 [0.95-1.06],0.928571600512595
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",38974,194,1.06 [0.85-1.33],0.6070883886829159
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39487,194,0.94 [0.72-1.23],0.6524831467587868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42388,96,0.81 [0.53-1.24],0.3266093635027066
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urethral stricture,38251,372,1.04 [0.88-1.24],0.6484095173240778
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urolithiasis,42956,664,0.96 [0.83-1.10],0.5593899953799686
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17592,118,0.90 [0.64-1.26],0.537367895012796
